COMPARISON OF PEDIATRIC PATIENTS WITH PARS PLANITIS WHO UNDERWENT TREATMENT VERSUS OBSERVATION AT A TERTIARY REFERRAL

Julia L Xia1, Jenny Shunyakova1, Kate M Hwang2

  • 1Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado.

PubMed

Insights

Not all pediatric pars planitis (PP) patients need treatment. Mild cases can be observed without complications, reducing medication side effects and burden.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology

Background:

  • Pars planitis (PP) is an inflammatory condition affecting the pediatric eye.
  • Treatment decisions for pediatric PP are often based on clinical presentation and severity.

Purpose of the Study:

  • To compare pediatric patients with pars planitis (PP) who received treatment versus those observed without treatment.
  • To identify characteristics of mild pediatric PP cases suitable for observation.

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with pars planitis (PP) between 2000 and 2024.
  • Analysis of clinical characteristics, fluorescein angiography (FA) scores, and treatment outcomes.

Main Results:

  • Out of 158 eyes, 127 (80.4%) were treated and 31 (19.6%) observed.
  • Observed eyes had significantly less inflammation (anterior chamber cell, vitreous cell, haze, optic nerve edema) and lower FA scores.
  • The treated group had higher rates of ocular hypertension and glaucoma; no untreated eyes developed complications requiring surgery. Final visual acuity was similar.

Conclusions:

  • Pediatric pars planitis (PP) does not always require treatment.
  • Mild cases can be safely observed, avoiding treatment-related side effects and medication burden.
  • Identifying suitable candidates for observation can optimize patient care and reduce complications.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
2.2K